Rubius Therapeutics Inc
(RUBY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RUBY | AZN | AMGN | GILD | BMY |
| Company | Rubius Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.0555 | 191.80 | 380.70 | 151.85 | 61.37 |
| High | 0.0570 | 192.76 | 384.62 | 153.00 | 61.63 |
| Low | 0.0550 | 187.46 | 372.34 | 150.18 | 60.45 |
| Latest | 0.0570 | 187.12 | 377.20 | 151.41 | 60.44 |
| Change | +0.0015 | -5.91 | -7.12 | -1.09 | -1.55 |
| % Change | +2.70% | -3.06% | -1.85% | -0.71% | -2.50% |
| Volume | 755,800 | 2,251,300 | 1,509,014 | 4,772,293 | 8,045,011 |
| 20-Day Average Volume | 190,760 | 4,789,688 | 3,051,247 | 8,056,976 | 13,384,239 |
| Previous Close | 0.0555 | 193.03 | 384.32 | 152.50 | 61.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0272 | 187.05 | 345.57 | 136.02 | 56.24 |
| 20-Day Raw Stochastic | 100.00% | 61.42% | 86.03% | 94.36% | 84.77% |
| 20-Day Relative Strength | 84.64 | 52.71 | 66.31 | 74.51 | 68.18 |
| Weighted Alpha | -42.49 | +31.74 | +37.20 | +54.41 | +24.40 |
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 24% Sell | 100% Buy | 96% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +185.00% since 12/21/23 | -0.30% since 02/02/26 | +9.08% since 02/02/26 | +5.84% since 02/02/26 | +8.70% since 02/02/26 |
| Low | 0.0200 on 12/22/23 | 183.63 on 02/03/26 | 338.59 on 02/03/26 | 142.03 on 02/03/26 | 55.49 on 02/03/26 |
| High | 0.0570 on 12/29/23 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | +200.00% since 11/29/23 | -0.77% since 01/09/26 | +15.30% since 01/09/26 | +24.89% since 01/09/26 | +8.76% since 01/09/26 |
| Low | 0.0181 on 12/01/23 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 0.0570 on 12/29/23 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +251.85% since 09/29/23 | +11.04% since 11/07/25 | +17.42% since 11/07/25 | +27.26% since 11/07/25 | +30.12% since 11/07/25 |
| Low | 0.0162 on 10/09/23 | 171.69 on 11/10/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 0.0570 on 12/29/23 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +216.67% since 06/29/23 | +27.70% since 08/08/25 | +30.45% since 08/08/25 | +26.66% since 08/08/25 | +32.22% since 08/08/25 |
| Low | 0.0032 on 09/25/23 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 0.1150 on 09/11/23 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,158 | 299,371,776 | 206,949,024 | 189,203,696 | 126,196,336 |
| Shares Outstanding, K | 90,483 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -179,670,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -20,140,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 2.20 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 01/01/70 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.48 | 16.83 | 18.24 | 9.68 |